← Back to Analyst Consensus 
DXCM Buy
DEXCOM INC
Current Price —
Implied Upside —
Analysts 35
30-Day Momentum
▲ 1 upgrades / ▼ 0 downgrades / 2 reiterations from 3 firms
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Oct 12, 2026 | BTIG | maintain | Buy → Buy | — | 52% |
| Oct 7, 2026 | Barclays | initiate | — → Overweight | — | 53% |
| Oct 1, 2026 | RBC Capital | maintain | Outperform → Outperform | — | 55% |
| Sep 18, 2026 | Truist Securities | maintain | Buy → Buy | — | 54% |
| Sep 18, 2026 | TD Cowen | reiterate | Buy → Buy | — | 54% |
| Aug 4, 2026 | Argus Research | maintain | Buy → Buy | — | 53% |
| Aug 3, 2026 | Canaccord Genuity | maintain | Buy → Buy | — | 48% |
| Jul 31, 2026 | Citigroup | maintain | Buy → Buy | — | 54% |
| Jul 31, 2026 | RBC Capital | maintain | Outperform → Outperform | — | 55% |
| Jul 31, 2026 | Mizuho | maintain | Outperform → Outperform | — | 52% |
| Jul 31, 2026 | JP Morgan | maintain | Neutral → Neutral | — | 54% |
| Jul 31, 2026 | Piper Sandler | reiterate | Overweight → Overweight | — | 54% |
| Jul 31, 2026 | Wells Fargo | maintain | Overweight → Overweight | — | 54% |
| Jul 31, 2026 | Stifel | maintain | Buy → Buy | — | 53% |
| Jul 31, 2026 | Benchmark | maintain | Buy → Buy | — | 54% |
| Jul 31, 2026 | Truist Securities | maintain | Buy → Buy | — | 54% |
| Jul 31, 2026 | BTIG | maintain | Buy → Buy | — | 52% |
| Jul 16, 2026 | Truist Securities | maintain | Buy → Buy | — | 54% |
| Jul 15, 2026 | Mizuho | maintain | Outperform → Outperform | — | 52% |
| Jun 23, 2026 | Deutsche Bank | initiate | Buy → Buy | — | 57% |
| Jun 15, 2026 | Piper Sandler | maintain | Overweight → Overweight | — | 54% |
| Jun 10, 2026 | TD Cowen | maintain | Buy → Buy | — | 54% |
| Jun 9, 2026 | Mizuho | maintain | Outperform → Outperform | — | 52% |
| Jun 5, 2026 | Stifel | maintain | Buy → Buy | — | 53% |
| May 28, 2026 | Citigroup | maintain | Buy → Buy | — | 54% |
| May 18, 2026 | Canaccord Genuity | maintain | Buy → Buy | — | 48% |
| May 18, 2026 | B of A Securities | maintain | Buy → Buy | — | 53% |
| May 18, 2026 | Barclays | maintain | Underweight → Underweight | — | 53% |
| May 4, 2026 | Citigroup | maintain | Buy → Buy | — | 54% |
| May 1, 2026 | Canaccord Genuity | maintain | Buy → Buy | — | 48% |
| May 1, 2026 | TD Cowen | maintain | Buy → Buy | — | 54% |
| May 1, 2026 | Barclays | maintain | Underweight → Underweight | — | 53% |
| Mar 11, 2026 | Citigroup | maintain | Buy → Buy | — | 54% |
| Mar 9, 2026 | BTIG | reiterate | Buy → Buy | — | 52% |
| Feb 25, 2026 | BTIG | reiterate | Buy → Buy | $85 | 52% |
| Feb 17, 2026 | Truist Securities | reiterate | Buy → Buy | $80 | 54% |
| Feb 13, 2026 | Canaccord Genuity | maintain | Buy → Buy | $95 | 48% |
| Feb 13, 2026 | Barclays | maintain | Underweight → Underweight | $72 | 53% |
| Feb 13, 2026 | Wells Fargo | maintain | Overweight → Overweight | $85 | 54% |
| Feb 13, 2026 | Mizuho | maintain | Outperform → Outperform | $90 | 52% |
| Feb 13, 2026 | BTIG | reiterate | Buy → Buy | $85 | 52% |
| Jan 12, 2026 | Barclays | downgrade | Equal-Weight → Underweight | $71 | 53% |
| Jan 9, 2026 | Bernstein | maintain | Outperform → Outperform | $86 | 52% |
| Dec 17, 2025 | Mizuho | maintain | Outperform → Outperform | $78 | 52% |
| Dec 11, 2025 | Citigroup | maintain | Buy → Buy | $77 | 54% |
| Dec 2, 2025 | Morgan Stanley | upgrade | Equal-Weight → Overweight | $75 | 54% |
| Nov 25, 2025 | Evercore ISI Group | initiate | — → In-Line | $68 | 58% |
| Nov 10, 2025 | Morgan Stanley | maintain | Equal-Weight → Equal-Weight | $63 | 54% |
| Nov 7, 2025 | Argus Research | maintain | Buy → Buy | $90 | 53% |
| Nov 3, 2025 | UBS | maintain | Buy → Buy | $95 | 54% |
Price Target Trend
Jul 25, 2026 Latest: $96.46 Oct 24, 2026
EPS Estimates
+1y $3.12
Lo: $2.83 Hi: $3.38
26 analysts 0y $2.66
Lo: $2.45 Hi: $2.75
26 analysts ▲1
+1q $0.74
Lo: $0.70 Hi: $0.77
22 analysts ▲1
0q $0.67
Lo: $0.63 Hi: $0.72
23 analysts ▲1
Cross-Platform Signals
No cross-platform signals in the last 90 days